6G5F: Botulinum neurotoxin type B

Crystal structure of an engineered Botulinum Neurotoxin type B mutant E1191M/S1199Y in complex with human synaptotagmin 1. Determined by X-ray diffraction at 2.5 Å resolution. Released 16 Jan 2019.

Method
X-ray diffraction
Resolution
2.5 Å
Organisms
Clostridium botulinum, Homo sapiens
Chains
3
Atoms
11,000
Mol. weight
304.98 kDa
Ligands
MLI
Released
16 Jan 2019

Explore 6G5F in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

6G5F contains 55 α-helices and 84 β-strands across 3 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain A: 21 helices, 31 β-strands

ElementResiduesLengthSheet
α-helix13-142
β-strand19-2351
α-helix25-273
β-strand34-4071
β-strand43-4641
α-helix56-594
β-strand64-6522
β-strand72-7323
β-strand7414
α-helix82-10019
α-helix103-11412
α-helix116-1183
β-strand128-12925
β-strand137-14151
α-helix1441
α-helix148-1492
β-strand151-15551
β-strand158-16141
β-strand16614
β-strand171-17331
β-strand176-17726
β-strand180-18126
α-helix182-1843
β-strand191-19441
β-strand199-20357
β-strand220-22127
α-helix222-2232
α-helix224-24017
α-helix247-2482
β-strand24918
β-strand25119
β-strand258110
β-strand26418
α-helix266-2727
α-helix276-2794
α-helix282-30524
β-strand308-30925
α-helix317-32711
β-strand331-332211
β-strand338-339211
α-helix342-3509
α-helix351-3555
α-helix358-3658
β-strand378-38367
β-strand393112
β-strand397112
α-helix407-4126
β-strand41317
α-helix418-4203
β-strand421-42227
β-strand429-43023
β-strand433-438613
Chain B: 33 helices, 53 β-strands
ElementResiduesLengthSheet
β-strand446-450513
α-helix451-4533
β-strand455110
α-helix4561
β-strand45819
α-helix460-4623
α-helix466-4683
β-strand471-473314
α-helix488-4925
α-helix502-5054
β-strand507-50821
α-helix509-5113
β-strand51716
β-strand524-52522
β-strand527-532613
α-helix537-5426
β-strand554-556315
α-helix559-5646
β-strand568-570315
α-helix575-5817
α-helix587-60519
α-helix624-6285
α-helix639-6468
α-helix647-6515
α-helix663-6653
β-strand666-668314
α-helix669-6702
α-helix675-70733
α-helix709-74032
α-helix745-7484
α-helix753-78230
α-helix783-7875
α-helix788-81225
α-helix821-83111
α-helix835-8384
α-helix840-8423
α-helix847-85711
α-helix860-8634
β-strand864-867416
β-strand868-870317
β-strand875-877317
β-strand884-887418
β-strand892-893216
β-strand898-902516
β-strand909-912418
β-strand926-933816
α-helix935-9384
α-helix942-9476
β-strand950-956718
β-strand961-967718
β-strand970-976718
β-strand982-988718
β-strand992119
β-strand1003-1009716
β-strand1013-1018616
β-strand1021-1027716
β-strand1039-1046818
β-strand1053-10621016
α-helix1068-107811
β-strand1083120
β-strand1085121
β-strand1091121
α-helix10921
β-strand1093122
β-strand1097-1102623
β-strand1108-1112523
α-helix11131
β-strand1119-1123523
β-strand1126124
β-strand1135119
β-strand1137124
β-strand1144-1149623
β-strand1160122
β-strand1162120
β-strand1166-1173823
β-strand1176-1181623
β-strand1182-1183225
β-strand1190-1192323
β-strand1194-1197423
β-strand1204-1205225
β-strand1208-1211423
β-strand1221-1225523
β-strand1236-1243823
β-strand1254-1260723
α-helix1262-12654
β-strand1280-1283423
Chain P: 1 helix, 0 β-strands
ElementResiduesLengthSheet
α-helix38-5215

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
Botulinum neurotoxin type BA, Bprotein1291Clostridium botulinumP10844 (AlphaFold model)
Synaptotagmin-1Pprotein21Homo sapiensP21579 (AlphaFold model)
Sequence of entity 1 (A, B), FASTA
>6G5F_1 Botulinum neurotoxin type B (chains A, B)
MPVTINNFNYNDPIDNNNIIMMEPPFARGTGRYYKAFKITDRIWIIPERYTFGYKPEDFN
KSSGIFNRDVCEYYDPDYLNTNDKKNIFLQTMIKLFNRIKSKPLGEKLLEMIINGIPYLG
DRRVPLEEFNTNIASVTVNKLISNPGEVERKKGIFANLIIFGPGPVLNENETIDIGIQNH
FASREGFGGIMQMKFCPEYVSVFNNVQENKGASIFNRRGYFSDPALILMHQLIYVLHGLY
GIKVDDLPIVPNEKKFFMQSTDAIQAEELYTFGGQDPSIITPSTDKSIYDKVLQNFRGIV
DRLNKVLVCISDPNININIYKNKFKDKYKFVEDSEGKYSIDVESFDKLYKSLMFGFTETN
IAENYKIKTRASYFSDSLPPVKIKNLLDNEIYTIEEGFNISDKDMEKEYRGQNKAINKQA
YEEISKEHLAVYKIQMCKSVKAPGICIDVDNEDLFFIADKNSFSDDLSKNERIEYNTQSN
YIENDFPINELILDTDLISKIELPSENTESLTDFNVDVPVYEKQPAIKKIFTDENTIFQY
LYSQTFPLDIRDISLTSSFDDALLFSNKVYSFFSMDYIKTANKVVEAGLFAGWVKQIVND
FVIEANKSNTMDKIADISLIVPYIGLALNVGNETAKGNFENAFEIAGASILLEFIPELLI
PVVGAFLLESYIDNKNKIIKTIDNALTKRNEKWSDMYGLIVAQWLSTVNTQFYTIKEGMY
KALNYQAQALEEIIKYRYNIYSEKEKSNINIDFNDINSKLNEGINQAIDNINNFINGCSV
SYLMKKMIPLAVEKLLDFDNTLKKNLLNYIDENKLYLIGSAEYEKSKVNKYLKTIMPFDL
SIYTNDTILIEMFNKYNSEILNNIILNLRYKDNNLIDLSGYGAKVEVYDGVELNDKNQFK
LTSSANSKIRVTQNQNIIFNSVFLDFSVSFWIRIPKYKNDGIQNYIHNEYTIINCMKNNS
GWKISIRGNRIIWTLIDINGKTKSVFFEYNIREDISEYINRWFFVTITNNLNNAKIYING
KLESNTDIKDIREVIANGEIIFKLDGDIDRTQFIWMKYFSIFNTELSQSNIEERYKIQSY
SEYLKDFWGNPLMYNKEYYMFNAGNKNSYIKLKKDSPVGEILTRSKYNQNSKYINYRDLY
IGEKFIIRRKSNSQSINDDIVRKEDYIYLDFFNLNQEWRVYTYKYFKKEEMKLFLAPIYD
SDEFYNTIQIKEYDEQPTYSCQLLFKKDEESTDEIGLIGIHRFYESGIVFEEYKDYFCIS
KWYLKEVKRKPYNLKLGCNWQFIPKDEGWTE
Sequence of entity 2 (P), FASTA
>6G5F_2 Synaptotagmin-1 (chains P)
GEGKEDAFSKLKEKFMNELHK

Ligands and cofactors

IDNameFormulaCopies
MLIMalonate ionC3 H2 O41

Water and common crystallization additives (GOL) are not listed.

Primary citation

Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models. Elliott, M., Favre-Guilmard, C., Liu, S.M. et al. Sci Adv (2019) 5:eaau7196-eaau7196. DOI 10.1126/sciadv.aau7196 · PubMed

Other PDB entries of the same protein (UniProt P10844 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 6G5F directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.